

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.46602342 |
| 2 | ATP synthesis coupled proton transport (GO:0015986) | 5.08486800 |
| 3 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.08486800 |
| 4 | proteasome assembly (GO:0043248) | 4.77918993 |
| 5 | establishment of integrated proviral latency (GO:0075713) | 4.74251472 |
| 6 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.63944957 |
| 7 | DNA deamination (GO:0045006) | 4.57688325 |
| 8 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 4.56055798 |
| 9 | protein maturation by protein folding (GO:0022417) | 4.50410470 |
| 10 | cullin deneddylation (GO:0010388) | 4.47282743 |
| 11 | protein deneddylation (GO:0000338) | 4.44988141 |
| 12 | respiratory electron transport chain (GO:0022904) | 4.42868188 |
| 13 | electron transport chain (GO:0022900) | 4.33060545 |
| 14 | deoxyribose phosphate biosynthetic process (GO:0046385) | 4.32969525 |
| 15 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 4.32969525 |
| 16 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.17536294 |
| 17 | establishment of viral latency (GO:0019043) | 4.00422964 |
| 18 | mitotic metaphase plate congression (GO:0007080) | 3.87648656 |
| 19 | regulation of mitotic spindle organization (GO:0060236) | 3.87632955 |
| 20 | chaperone-mediated protein transport (GO:0072321) | 3.82053246 |
| 21 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.66967658 |
| 22 | L-serine metabolic process (GO:0006563) | 3.66347028 |
| 23 | establishment of protein localization to mitochondrion (GO:0072655) | 3.56449844 |
| 24 | protein targeting to mitochondrion (GO:0006626) | 3.56014470 |
| 25 | regulation of mitochondrial translation (GO:0070129) | 3.54712928 |
| 26 | protein localization to mitochondrion (GO:0070585) | 3.52335153 |
| 27 | deoxyribonucleotide biosynthetic process (GO:0009263) | 3.51572534 |
| 28 | mitotic sister chromatid segregation (GO:0000070) | 3.50638156 |
| 29 | protein neddylation (GO:0045116) | 3.48149166 |
| 30 | protein complex biogenesis (GO:0070271) | 3.43616344 |
| 31 | DNA unwinding involved in DNA replication (GO:0006268) | 3.41768401 |
| 32 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.41353971 |
| 33 | nuclear envelope reassembly (GO:0031468) | 3.39422697 |
| 34 | mitotic nuclear envelope reassembly (GO:0007084) | 3.39422697 |
| 35 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.36544619 |
| 36 | Golgi transport vesicle coating (GO:0048200) | 3.31091800 |
| 37 | COPI coating of Golgi vesicle (GO:0048205) | 3.31091800 |
| 38 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 3.30656957 |
| 39 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.30319955 |
| 40 | oxidative phosphorylation (GO:0006119) | 3.29804228 |
| 41 | regulation of spindle organization (GO:0090224) | 3.27714745 |
| 42 | ribosomal large subunit biogenesis (GO:0042273) | 3.27433087 |
| 43 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.24183431 |
| 44 | metaphase plate congression (GO:0051310) | 3.23805513 |
| 45 | DNA strand elongation (GO:0022616) | 3.22093268 |
| 46 | synaptic vesicle exocytosis (GO:0016079) | 3.20734237 |
| 47 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.19570549 |
| 48 | CENP-A containing nucleosome assembly (GO:0034080) | 3.19423618 |
| 49 | mitotic chromosome condensation (GO:0007076) | 3.19239226 |
| 50 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.17826362 |
| 51 | NADH dehydrogenase complex assembly (GO:0010257) | 3.17826362 |
| 52 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.17826362 |
| 53 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.11748458 |
| 54 | chromatin remodeling at centromere (GO:0031055) | 3.10030958 |
| 55 | protein localization to chromosome, centromeric region (GO:0071459) | 3.10001988 |
| 56 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.09484965 |
| 57 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.08928768 |
| 58 | sister chromatid segregation (GO:0000819) | 3.07494076 |
| 59 | negative regulation of cation channel activity (GO:2001258) | 3.05445692 |
| 60 | GTP biosynthetic process (GO:0006183) | 3.05178812 |
| 61 | membrane budding (GO:0006900) | 3.04264026 |
| 62 | protein retention in ER lumen (GO:0006621) | 2.99880744 |
| 63 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.99795722 |
| 64 | positive regulation of vesicle fusion (GO:0031340) | 2.98900508 |
| 65 | purine nucleobase biosynthetic process (GO:0009113) | 2.98664857 |
| 66 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.91997510 |
| 67 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.91911245 |
| 68 | de novo protein folding (GO:0006458) | 2.89784667 |
| 69 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.89541416 |
| 70 | negative regulation of ligase activity (GO:0051352) | 2.89541416 |
| 71 | ribosome assembly (GO:0042255) | 2.89369016 |
| 72 | inner mitochondrial membrane organization (GO:0007007) | 2.87627663 |
| 73 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.86968164 |
| 74 | GDP-mannose metabolic process (GO:0019673) | 2.86747754 |
| 75 | protein localization to kinetochore (GO:0034501) | 2.85698358 |
| 76 | regulation of vesicle fusion (GO:0031338) | 2.85234268 |
| 77 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.84819494 |
| 78 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.84819494 |
| 79 | regulation of synaptic vesicle transport (GO:1902803) | 2.83858308 |
| 80 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 2.83783478 |
| 81 | negative regulation of microtubule polymerization (GO:0031115) | 2.82815083 |
| 82 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.81927277 |
| 83 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.81927277 |
| 84 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.81802630 |
| 85 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.81334120 |
| 86 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.81334120 |
| 87 | protein complex localization (GO:0031503) | 2.81279919 |
| 88 | formation of translation preinitiation complex (GO:0001731) | 2.80629204 |
| 89 | ribonucleoprotein complex disassembly (GO:0032988) | 2.80497762 |
| 90 | cellular protein complex localization (GO:0034629) | 2.79553078 |
| 91 | regulation of ligase activity (GO:0051340) | 2.78235634 |
| 92 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.77593634 |
| 93 | ventricular cardiac muscle cell development (GO:0055015) | 2.76286499 |
| 94 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.75529118 |
| 95 | respiratory chain complex IV assembly (GO:0008535) | 2.73783976 |
| 96 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.73211003 |
| 97 | protein peptidyl-prolyl isomerization (GO:0000413) | 2.72969830 |
| 98 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.71707591 |
| 99 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.70251736 |
| 100 | regulation of protein heterodimerization activity (GO:0043497) | 2.69392468 |
| 101 | neuronal action potential propagation (GO:0019227) | 2.69140274 |
| 102 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.69052623 |
| 103 | de novo posttranslational protein folding (GO:0051084) | 2.67016031 |
| 104 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.66642139 |
| 105 | DNA replication checkpoint (GO:0000076) | 2.66613871 |
| 106 | positive regulation of ligase activity (GO:0051351) | 2.65362872 |
| 107 | ribosomal small subunit biogenesis (GO:0042274) | 2.63388811 |
| 108 | glutamate secretion (GO:0014047) | 2.62242431 |
| 109 | mitochondrial transport (GO:0006839) | 2.61993357 |
| 110 | hydrogen ion transmembrane transport (GO:1902600) | 2.61944319 |
| 111 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.60008494 |
| 112 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.59739584 |
| 113 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.59739584 |
| 114 | cytochrome complex assembly (GO:0017004) | 2.59736564 |
| 115 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.59566653 |
| 116 | establishment of chromosome localization (GO:0051303) | 2.58902331 |
| 117 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.58541950 |
| 118 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.57755793 |
| 119 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.57755793 |
| 120 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.57755793 |
| 121 | IMP biosynthetic process (GO:0006188) | 2.57313931 |
| 122 | regulation of cofactor metabolic process (GO:0051193) | 2.56509776 |
| 123 | regulation of coenzyme metabolic process (GO:0051196) | 2.56509776 |
| 124 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.54148032 |
| 125 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.53769655 |
| 126 | CTP metabolic process (GO:0046036) | 2.53305203 |
| 127 | CTP biosynthetic process (GO:0006241) | 2.53305203 |
| 128 | telomere maintenance via recombination (GO:0000722) | 2.52615865 |
| 129 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.52103041 |
| 130 | positive regulation of mitochondrial fission (GO:0090141) | 2.51856857 |
| 131 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.51524341 |
| 132 | maturation of SSU-rRNA (GO:0030490) | 2.48539330 |
| 133 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.47891533 |
| 134 | protein heterotetramerization (GO:0051290) | 2.47687760 |
| 135 | tRNA aminoacylation for protein translation (GO:0006418) | 2.47100381 |
| 136 | kinetochore organization (GO:0051383) | 2.46218124 |
| 137 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.45952715 |
| 138 | cell cycle G1/S phase transition (GO:0044843) | 2.45952715 |
| 139 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.45824963 |
| 140 | regulation of cellular amine metabolic process (GO:0033238) | 2.45688707 |
| 141 | nucleoside diphosphate phosphorylation (GO:0006165) | 2.44537195 |
| 142 | DNA replication-independent nucleosome organization (GO:0034724) | 2.43684638 |
| 143 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.43684638 |
| 144 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.43377261 |
| 145 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.43377261 |
| 146 | regulation of chromosome segregation (GO:0051983) | 2.42776276 |
| 147 | transferrin transport (GO:0033572) | 2.42769630 |
| 148 | regulation of neuron projection regeneration (GO:0070570) | 2.42646596 |
| 149 | regulation of axon regeneration (GO:0048679) | 2.42646596 |
| 150 | IMP metabolic process (GO:0046040) | 2.42465647 |
| 151 | peptidyl-proline modification (GO:0018208) | 2.42145579 |
| 152 | response to misfolded protein (GO:0051788) | 2.42042806 |
| 153 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.41992808 |
| 154 | mitotic recombination (GO:0006312) | 2.41966663 |
| 155 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.41476430 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.78938525 |
| 2 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.29064271 |
| 3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.26951908 |
| 4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.75939607 |
| 5 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.55663144 |
| 6 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.43712583 |
| 7 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.17827890 |
| 8 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.07583520 |
| 9 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.90453439 |
| 10 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.86796731 |
| 11 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.80202422 |
| 12 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.75631326 |
| 13 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.67395487 |
| 14 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.65464336 |
| 15 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.64108971 |
| 16 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.62897518 |
| 17 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.56523829 |
| 18 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.51769704 |
| 19 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.50553435 |
| 20 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.50549903 |
| 21 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.49278744 |
| 22 | VDR_22108803_ChIP-Seq_LS180_Human | 2.42002966 |
| 23 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.40851762 |
| 24 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.37468493 |
| 25 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.34601241 |
| 26 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.30400639 |
| 27 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.21930166 |
| 28 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 2.19668817 |
| 29 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.18544467 |
| 30 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.15222142 |
| 31 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.11547192 |
| 32 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.09930709 |
| 33 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.09819675 |
| 34 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 2.08973402 |
| 35 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.06039743 |
| 36 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.04353625 |
| 37 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.03877195 |
| 38 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.95436283 |
| 39 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.95294538 |
| 40 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.91575880 |
| 41 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.86757792 |
| 42 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.84852833 |
| 43 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.84517512 |
| 44 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.76440733 |
| 45 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.76254108 |
| 46 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.76058717 |
| 47 | * TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 1.75817626 |
| 48 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.68879699 |
| 49 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.67956994 |
| 50 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.67829909 |
| 51 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.64098619 |
| 52 | * CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.60158290 |
| 53 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.59212044 |
| 54 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.57589939 |
| 55 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.52744280 |
| 56 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.51328959 |
| 57 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.51187637 |
| 58 | FUS_26573619_Chip-Seq_HEK293_Human | 1.49566253 |
| 59 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.46607946 |
| 60 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.46385514 |
| 61 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.45609615 |
| 62 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.45363867 |
| 63 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.45194092 |
| 64 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.44960262 |
| 65 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.43196004 |
| 66 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.39051403 |
| 67 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.38107166 |
| 68 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.36581927 |
| 69 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.33516965 |
| 70 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.33042685 |
| 71 | JUN_21703547_ChIP-Seq_K562_Human | 1.32107437 |
| 72 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.32008358 |
| 73 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.30807033 |
| 74 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.30339024 |
| 75 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.29807521 |
| 76 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.28064442 |
| 77 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.27709263 |
| 78 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.26722779 |
| 79 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.25650079 |
| 80 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.25277748 |
| 81 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 1.24998044 |
| 82 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.24221008 |
| 83 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.23129183 |
| 84 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.23109773 |
| 85 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.22999369 |
| 86 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.22643427 |
| 87 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.22494860 |
| 88 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.21161084 |
| 89 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.20530810 |
| 90 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.19796260 |
| 91 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.19508423 |
| 92 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.18594338 |
| 93 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.18106285 |
| 94 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.17913341 |
| 95 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.17379306 |
| 96 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.17027665 |
| 97 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.16751012 |
| 98 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.15799594 |
| 99 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.13548362 |
| 100 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.13093816 |
| 101 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.12913337 |
| 102 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.12054565 |
| 103 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.11861847 |
| 104 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.11340938 |
| 105 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.11273247 |
| 106 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.10050638 |
| 107 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.10043445 |
| 108 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.09653076 |
| 109 | EWS_26573619_Chip-Seq_HEK293_Human | 1.08491371 |
| 110 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.08487611 |
| 111 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.07452236 |
| 112 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.06461884 |
| 113 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.06437235 |
| 114 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.06000801 |
| 115 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.05441514 |
| 116 | * TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 1.05391605 |
| 117 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.05390611 |
| 118 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.05129238 |
| 119 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.04276964 |
| 120 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.03401055 |
| 121 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.03228860 |
| 122 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.03055429 |
| 123 | P300_19829295_ChIP-Seq_ESCs_Human | 1.02884552 |
| 124 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02291591 |
| 125 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.01988121 |
| 126 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01886171 |
| 127 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.01814097 |
| 128 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.01123399 |
| 129 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.99242152 |
| 130 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.99233190 |
| 131 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.98545104 |
| 132 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.97136776 |
| 133 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.96965773 |
| 134 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.96593733 |
| 135 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.95777644 |
| 136 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.95704648 |
| 137 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.95197249 |
| 138 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.94009094 |
| 139 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.92991204 |
| 140 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.90488442 |
| 141 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.90310697 |
| 142 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.88838050 |
| 143 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.88706062 |
| 144 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.88424535 |
| 145 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.86369506 |
| 146 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.86366149 |
| 147 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.81604789 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 3.46899605 |
| 2 | MP0006276_abnormal_autonomic_nervous | 3.40183166 |
| 3 | MP0002735_abnormal_chemical_nociception | 3.05264103 |
| 4 | MP0003111_abnormal_nucleus_morphology | 2.97983023 |
| 5 | MP0004859_abnormal_synaptic_plasticity | 2.91279999 |
| 6 | MP0001968_abnormal_touch/_nociception | 2.85730215 |
| 7 | MP0009379_abnormal_foot_pigmentation | 2.83801635 |
| 8 | MP0001188_hyperpigmentation | 2.76480638 |
| 9 | MP0010094_abnormal_chromosome_stability | 2.66254480 |
| 10 | MP0000013_abnormal_adipose_tissue | 2.56534121 |
| 11 | MP0004270_analgesia | 2.53055537 |
| 12 | MP0002736_abnormal_nociception_after | 2.50787027 |
| 13 | MP0003077_abnormal_cell_cycle | 2.48272049 |
| 14 | MP0003806_abnormal_nucleotide_metabolis | 2.44708092 |
| 15 | MP0002734_abnormal_mechanical_nocicepti | 2.38334533 |
| 16 | MP0008007_abnormal_cellular_replicative | 2.37287874 |
| 17 | MP0010386_abnormal_urinary_bladder | 2.30874064 |
| 18 | MP0002733_abnormal_thermal_nociception | 2.18990519 |
| 19 | MP0005623_abnormal_meninges_morphology | 2.17154708 |
| 20 | MP0002638_abnormal_pupillary_reflex | 2.10546133 |
| 21 | MP0001905_abnormal_dopamine_level | 2.07460214 |
| 22 | MP0008058_abnormal_DNA_repair | 2.06185713 |
| 23 | MP0004858_abnormal_nervous_system | 2.05764243 |
| 24 | MP0003635_abnormal_synaptic_transmissio | 2.05216589 |
| 25 | MP0001970_abnormal_pain_threshold | 2.03762363 |
| 26 | MP0001986_abnormal_taste_sensitivity | 1.98703716 |
| 27 | MP0005058_abnormal_lysosome_morphology | 1.98628652 |
| 28 | MP0001501_abnormal_sleep_pattern | 1.96787523 |
| 29 | MP0001440_abnormal_grooming_behavior | 1.96642740 |
| 30 | MP0003693_abnormal_embryo_hatching | 1.89121921 |
| 31 | MP0009745_abnormal_behavioral_response | 1.79099721 |
| 32 | MP0002234_abnormal_pharynx_morphology | 1.78602446 |
| 33 | MP0003123_paternal_imprinting | 1.76371876 |
| 34 | MP0002063_abnormal_learning/memory/cond | 1.73698437 |
| 35 | MP0010030_abnormal_orbit_morphology | 1.68299721 |
| 36 | MP0001542_abnormal_bone_strength | 1.66907519 |
| 37 | MP0002909_abnormal_adrenal_gland | 1.66374066 |
| 38 | MP0005084_abnormal_gallbladder_morpholo | 1.65123398 |
| 39 | MP0000750_abnormal_muscle_regeneration | 1.62784557 |
| 40 | MP0001730_embryonic_growth_arrest | 1.58614093 |
| 41 | MP0004145_abnormal_muscle_electrophysio | 1.57137495 |
| 42 | MP0002184_abnormal_innervation | 1.54991615 |
| 43 | MP0000749_muscle_degeneration | 1.54156529 |
| 44 | MP0002837_dystrophic_cardiac_calcinosis | 1.52445347 |
| 45 | MP0003646_muscle_fatigue | 1.50616340 |
| 46 | MP0002090_abnormal_vision | 1.47923782 |
| 47 | MP0004215_abnormal_myocardial_fiber | 1.47859408 |
| 48 | MP0002067_abnormal_sensory_capabilities | 1.47816212 |
| 49 | MP0001529_abnormal_vocalization | 1.46605436 |
| 50 | MP0000350_abnormal_cell_proliferation | 1.46044309 |
| 51 | MP0006036_abnormal_mitochondrial_physio | 1.44320234 |
| 52 | MP0009046_muscle_twitch | 1.43849590 |
| 53 | MP0002572_abnormal_emotion/affect_behav | 1.42855929 |
| 54 | MP0002064_seizures | 1.42775429 |
| 55 | MP0000647_abnormal_sebaceous_gland | 1.42126259 |
| 56 | MP0003279_aneurysm | 1.41495109 |
| 57 | MP0005257_abnormal_intraocular_pressure | 1.41058235 |
| 58 | MP0004272_abnormal_basement_membrane | 1.36617166 |
| 59 | MP0003329_amyloid_beta_deposits | 1.35699889 |
| 60 | MP0006292_abnormal_olfactory_placode | 1.35425117 |
| 61 | MP0003718_maternal_effect | 1.34782366 |
| 62 | MP0002272_abnormal_nervous_system | 1.33430267 |
| 63 | MP0006035_abnormal_mitochondrial_morpho | 1.32021697 |
| 64 | MP0004233_abnormal_muscle_weight | 1.26384547 |
| 65 | MP0004142_abnormal_muscle_tone | 1.24989762 |
| 66 | MP0002751_abnormal_autonomic_nervous | 1.24759372 |
| 67 | MP0002332_abnormal_exercise_endurance | 1.23583626 |
| 68 | MP0005386_behavior/neurological_phenoty | 1.22852765 |
| 69 | MP0004924_abnormal_behavior | 1.22852765 |
| 70 | MP0004484_altered_response_of | 1.21710247 |
| 71 | MP0000681_abnormal_thyroid_gland | 1.17974611 |
| 72 | MP0001697_abnormal_embryo_size | 1.16256967 |
| 73 | MP0004957_abnormal_blastocyst_morpholog | 1.15897340 |
| 74 | MP0003566_abnormal_cell_adhesion | 1.12234969 |
| 75 | MP0001299_abnormal_eye_distance/ | 1.10529592 |
| 76 | MP0002697_abnormal_eye_size | 1.09861669 |
| 77 | MP0000358_abnormal_cell_content/ | 1.09327501 |
| 78 | MP0005535_abnormal_body_temperature | 1.09138623 |
| 79 | MP0005165_increased_susceptibility_to | 1.08836104 |
| 80 | MP0002080_prenatal_lethality | 1.08830308 |
| 81 | MP0005501_abnormal_skin_physiology | 1.07830838 |
| 82 | MP0001502_abnormal_circadian_rhythm | 1.07824627 |
| 83 | MP0009697_abnormal_copulation | 1.06886935 |
| 84 | MP0000747_muscle_weakness | 1.04958010 |
| 85 | MP0008789_abnormal_olfactory_epithelium | 1.04877408 |
| 86 | MP0005503_abnormal_tendon_morphology | 1.03626734 |
| 87 | MP0000537_abnormal_urethra_morphology | 1.03438183 |
| 88 | MP0000751_myopathy | 1.02342273 |
| 89 | MP0004811_abnormal_neuron_physiology | 1.02027629 |
| 90 | MP0003950_abnormal_plasma_membrane | 1.01807953 |
| 91 | MP0003941_abnormal_skin_development | 1.00871887 |
| 92 | MP0008932_abnormal_embryonic_tissue | 1.00709628 |
| 93 | MP0000372_irregular_coat_pigmentation | 1.00672851 |
| 94 | MP0001984_abnormal_olfaction | 1.00526837 |
| 95 | MP0003879_abnormal_hair_cell | 0.99704187 |
| 96 | MP0003786_premature_aging | 0.97505452 |
| 97 | MP0001672_abnormal_embryogenesis/_devel | 0.96258645 |
| 98 | MP0005380_embryogenesis_phenotype | 0.96258645 |
| 99 | MP0003136_yellow_coat_color | 0.95459905 |
| 100 | MP0004510_myositis | 0.94672543 |
| 101 | MP0005187_abnormal_penis_morphology | 0.92981417 |
| 102 | MP0002693_abnormal_pancreas_physiology | 0.92555942 |
| 103 | MP0003186_abnormal_redox_activity | 0.92552769 |
| 104 | MP0008260_abnormal_autophagy | 0.92125089 |
| 105 | MP0003656_abnormal_erythrocyte_physiolo | 0.91574978 |
| 106 | MP0003195_calcinosis | 0.91413973 |
| 107 | MP0000313_abnormal_cell_death | 0.89630420 |
| 108 | MP0005384_cellular_phenotype | 0.88988283 |
| 109 | MP0002085_abnormal_embryonic_tissue | 0.88528100 |
| 110 | MP0001727_abnormal_embryo_implantation | 0.88304727 |
| 111 | MP0005197_abnormal_uvea_morphology | 0.86829559 |
| 112 | MP0002269_muscular_atrophy | 0.86511559 |
| 113 | MP0003221_abnormal_cardiomyocyte_apopto | 0.86020057 |
| 114 | MP0002092_abnormal_eye_morphology | 0.85683607 |
| 115 | MP0005330_cardiomyopathy | 0.85174971 |
| 116 | MP0003122_maternal_imprinting | 0.84904877 |
| 117 | MP0006072_abnormal_retinal_apoptosis | 0.84869089 |
| 118 | MP0003937_abnormal_limbs/digits/tail_de | 0.84477444 |
| 119 | MP0002972_abnormal_cardiac_muscle | 0.83447602 |
| 120 | MP0009053_abnormal_anal_canal | 0.83390734 |
| 121 | MP0004147_increased_porphyrin_level | 0.82082358 |
| 122 | MP0003385_abnormal_body_wall | 0.82076370 |
| 123 | MP0009840_abnormal_foam_cell | 0.82046398 |
| 124 | MP0005379_endocrine/exocrine_gland_phen | 0.81373045 |
| 125 | MP0005620_abnormal_muscle_contractility | 0.80173401 |
| 126 | MP0005499_abnormal_olfactory_system | 0.79546250 |
| 127 | MP0005394_taste/olfaction_phenotype | 0.79546250 |
| 128 | MP0002084_abnormal_developmental_patter | 0.79264183 |
| 129 | MP0005171_absent_coat_pigmentation | 0.79171752 |
| 130 | MP0005275_abnormal_skin_tensile | 0.79070742 |
| 131 | MP0001853_heart_inflammation | 0.78958282 |
| 132 | MP0000343_altered_response_to | 0.77853218 |
| 133 | MP0001293_anophthalmia | 0.77678142 |
| 134 | MP0005595_abnormal_vascular_smooth | 0.77620357 |
| 135 | MP0001348_abnormal_lacrimal_gland | 0.77140868 |
| 136 | MP0005451_abnormal_body_composition | 0.76942215 |
| 137 | MP0002160_abnormal_reproductive_system | 0.75937126 |
| 138 | MP0001919_abnormal_reproductive_system | 0.75924239 |
| 139 | MP0005164_abnormal_response_to | 0.75319240 |
| 140 | MP0002557_abnormal_social/conspecific_i | 0.75022121 |
| 141 | MP0003984_embryonic_growth_retardation | 0.74968445 |
| 142 | MP0002177_abnormal_outer_ear | 0.74921445 |
| 143 | MP0003634_abnormal_glial_cell | 0.74110521 |
| 144 | MP0000759_abnormal_skeletal_muscle | 0.73995462 |
| 145 | MP0010352_gastrointestinal_tract_polyps | 0.73912371 |
| 146 | MP0002066_abnormal_motor_capabilities/c | 0.73839686 |
| 147 | MP0003137_abnormal_impulse_conducting | 0.73211353 |
| 148 | MP0008438_abnormal_cutaneous_collagen | 0.73067311 |
| 149 | MP0000955_abnormal_spinal_cord | 0.72943593 |
| 150 | MP0003705_abnormal_hypodermis_morpholog | 0.72900659 |
| 151 | MP0001881_abnormal_mammary_gland | 0.72743730 |
| 152 | MP0009672_abnormal_birth_weight | 0.71725056 |
| 153 | MP0002938_white_spotting | 0.71697283 |
| 154 | MP0002106_abnormal_muscle_physiology | 0.71179518 |
| 155 | MP0003315_abnormal_perineum_morphology | 0.70869524 |
| 156 | MP0002877_abnormal_melanocyte_morpholog | 0.70842047 |
| 157 | MP0002233_abnormal_nose_morphology | 0.70644235 |
| 158 | MP0005645_abnormal_hypothalamus_physiol | 0.70320261 |
| 159 | MP0005248_abnormal_Harderian_gland | 0.69818207 |
| 160 | MP0005621_abnormal_cell_physiology | 0.69731074 |
| 161 | MP0003453_abnormal_keratinocyte_physiol | 0.68904747 |
| 162 | MP0001486_abnormal_startle_reflex | 0.68887924 |
| 163 | MP0008775_abnormal_heart_ventricle | 0.68279300 |
| 164 | MP0000538_abnormal_urinary_bladder | 0.67710139 |
| 165 | MP0001664_abnormal_digestion | 0.66319842 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 4.98481876 |
| 2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.65322633 |
| 3 | Mitochondrial inheritance (HP:0001427) | 4.42174175 |
| 4 | Progressive macrocephaly (HP:0004481) | 4.21931763 |
| 5 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 4.16103549 |
| 6 | Abnormality of alanine metabolism (HP:0010916) | 4.16103549 |
| 7 | Hyperalaninemia (HP:0003348) | 4.16103549 |
| 8 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.87593452 |
| 9 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.87593452 |
| 10 | Hepatocellular necrosis (HP:0001404) | 3.86419996 |
| 11 | Cortical dysplasia (HP:0002539) | 3.83446750 |
| 12 | Increased CSF lactate (HP:0002490) | 3.80093991 |
| 13 | Hepatic necrosis (HP:0002605) | 3.60572693 |
| 14 | Acute encephalopathy (HP:0006846) | 3.55558769 |
| 15 | Hypothermia (HP:0002045) | 3.41849260 |
| 16 | Visual hallucinations (HP:0002367) | 3.32377912 |
| 17 | Abnormality of the anterior horn cell (HP:0006802) | 3.22918627 |
| 18 | Degeneration of anterior horn cells (HP:0002398) | 3.22918627 |
| 19 | Neuroendocrine neoplasm (HP:0100634) | 3.21505784 |
| 20 | Pheochromocytoma (HP:0002666) | 3.08720009 |
| 21 | Increased hepatocellular lipid droplets (HP:0006565) | 3.02290247 |
| 22 | Upper limb muscle weakness (HP:0003484) | 2.98629319 |
| 23 | Dysautonomia (HP:0002459) | 2.96532044 |
| 24 | Retinal dysplasia (HP:0007973) | 2.95797856 |
| 25 | Lactic acidosis (HP:0003128) | 2.87460391 |
| 26 | Exercise intolerance (HP:0003546) | 2.86729181 |
| 27 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.82310413 |
| 28 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.82310413 |
| 29 | Focal motor seizures (HP:0011153) | 2.79234562 |
| 30 | Delusions (HP:0000746) | 2.77481807 |
| 31 | Respiratory failure (HP:0002878) | 2.71005011 |
| 32 | Increased serum lactate (HP:0002151) | 2.68683896 |
| 33 | Shoulder girdle muscle weakness (HP:0003547) | 2.66667685 |
| 34 | Myokymia (HP:0002411) | 2.66416813 |
| 35 | Increased intramyocellular lipid droplets (HP:0012240) | 2.58307702 |
| 36 | Delayed gross motor development (HP:0002194) | 2.56521161 |
| 37 | Lipid accumulation in hepatocytes (HP:0006561) | 2.56496683 |
| 38 | Abnormal autonomic nervous system physiology (HP:0012332) | 2.53024581 |
| 39 | Cholecystitis (HP:0001082) | 2.52831714 |
| 40 | Abnormal gallbladder physiology (HP:0012438) | 2.52831714 |
| 41 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.52250152 |
| 42 | Absence seizures (HP:0002121) | 2.46828236 |
| 43 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.46760473 |
| 44 | Type II lissencephaly (HP:0007260) | 2.45889839 |
| 45 | Unsteady gait (HP:0002317) | 2.42961049 |
| 46 | Vertebral compression fractures (HP:0002953) | 2.31035352 |
| 47 | Microretrognathia (HP:0000308) | 2.28031325 |
| 48 | Microvesicular hepatic steatosis (HP:0001414) | 2.27458752 |
| 49 | Emotional lability (HP:0000712) | 2.27021716 |
| 50 | Multiple enchondromatosis (HP:0005701) | 2.26410462 |
| 51 | Hypokinesia (HP:0002375) | 2.25619016 |
| 52 | Insomnia (HP:0100785) | 2.24666347 |
| 53 | Fasciculations (HP:0002380) | 2.24573730 |
| 54 | Atonic seizures (HP:0010819) | 2.23817775 |
| 55 | Renal Fanconi syndrome (HP:0001994) | 2.21041670 |
| 56 | Spastic diplegia (HP:0001264) | 2.18999810 |
| 57 | Myotonia (HP:0002486) | 2.17504055 |
| 58 | Exercise-induced muscle cramps (HP:0003710) | 2.16861976 |
| 59 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.16579841 |
| 60 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.16579841 |
| 61 | Abnormality of glycolipid metabolism (HP:0010969) | 2.16579841 |
| 62 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.14736462 |
| 63 | Optic disc pallor (HP:0000543) | 2.11924973 |
| 64 | Insidious onset (HP:0003587) | 2.10217585 |
| 65 | Termporal pattern (HP:0011008) | 2.10217585 |
| 66 | Ulnar claw (HP:0001178) | 2.09859154 |
| 67 | Increased serum pyruvate (HP:0003542) | 2.09507580 |
| 68 | Abnormality of glycolysis (HP:0004366) | 2.09507580 |
| 69 | Pelvic girdle muscle weakness (HP:0003749) | 2.09401426 |
| 70 | Nuclear cataract (HP:0100018) | 2.07463397 |
| 71 | Increased muscle lipid content (HP:0009058) | 2.06241181 |
| 72 | Overriding aorta (HP:0002623) | 2.05903946 |
| 73 | Exertional dyspnea (HP:0002875) | 2.05903801 |
| 74 | Reticulocytopenia (HP:0001896) | 2.05095774 |
| 75 | Cerebral hypomyelination (HP:0006808) | 2.04828281 |
| 76 | Hyperparathyroidism (HP:0000843) | 2.03486747 |
| 77 | Birth length less than 3rd percentile (HP:0003561) | 2.03180031 |
| 78 | Limb dystonia (HP:0002451) | 2.02702173 |
| 79 | Cerebral edema (HP:0002181) | 1.99397484 |
| 80 | Increased nuchal translucency (HP:0010880) | 1.99380066 |
| 81 | Postnatal microcephaly (HP:0005484) | 1.98211592 |
| 82 | Reduced antithrombin III activity (HP:0001976) | 1.97341449 |
| 83 | Dialeptic seizures (HP:0011146) | 1.96927495 |
| 84 | X-linked dominant inheritance (HP:0001423) | 1.96300132 |
| 85 | Distal lower limb amyotrophy (HP:0008944) | 1.96063677 |
| 86 | Ragged-red muscle fibers (HP:0003200) | 1.95072184 |
| 87 | Gait imbalance (HP:0002141) | 1.93204945 |
| 88 | Orthostatic hypotension (HP:0001278) | 1.92973142 |
| 89 | Type I transferrin isoform profile (HP:0003642) | 1.92797572 |
| 90 | Limb-girdle muscle atrophy (HP:0003797) | 1.92011909 |
| 91 | Anxiety (HP:0000739) | 1.91067325 |
| 92 | Abnormality of the tricuspid valve (HP:0001702) | 1.89597334 |
| 93 | Lower limb amyotrophy (HP:0007210) | 1.89576856 |
| 94 | Hypercortisolism (HP:0001578) | 1.88045122 |
| 95 | Medial flaring of the eyebrow (HP:0010747) | 1.87182596 |
| 96 | Macrocytic anemia (HP:0001972) | 1.86104842 |
| 97 | Lissencephaly (HP:0001339) | 1.85475157 |
| 98 | Myoglobinuria (HP:0002913) | 1.84748280 |
| 99 | Median cleft lip (HP:0000161) | 1.84075114 |
| 100 | Abnormal protein glycosylation (HP:0012346) | 1.83001153 |
| 101 | Abnormal glycosylation (HP:0012345) | 1.83001153 |
| 102 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.83001153 |
| 103 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.83001153 |
| 104 | Sensorimotor neuropathy (HP:0007141) | 1.82891172 |
| 105 | Epileptic encephalopathy (HP:0200134) | 1.82022381 |
| 106 | Congenital primary aphakia (HP:0007707) | 1.81342822 |
| 107 | Poor head control (HP:0002421) | 1.81170334 |
| 108 | Patent foramen ovale (HP:0001655) | 1.80918710 |
| 109 | 3-Methylglutaconic aciduria (HP:0003535) | 1.80340149 |
| 110 | Amblyopia (HP:0000646) | 1.79235638 |
| 111 | Abnormality of the umbilical cord (HP:0010881) | 1.78796409 |
| 112 | Premature rupture of membranes (HP:0001788) | 1.76860484 |
| 113 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.76738831 |
| 114 | Leukodystrophy (HP:0002415) | 1.76720542 |
| 115 | Gout (HP:0001997) | 1.75850194 |
| 116 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.74957548 |
| 117 | Nausea (HP:0002018) | 1.74870800 |
| 118 | Progressive muscle weakness (HP:0003323) | 1.74771730 |
| 119 | CNS demyelination (HP:0007305) | 1.74190842 |
| 120 | Respiratory difficulties (HP:0002880) | 1.74168654 |
| 121 | Achilles tendon contracture (HP:0001771) | 1.74019626 |
| 122 | Agitation (HP:0000713) | 1.73907659 |
| 123 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.73315414 |
| 124 | Abnormal number of erythroid precursors (HP:0012131) | 1.73216263 |
| 125 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.73010800 |
| 126 | Neuroblastoma (HP:0003006) | 1.70883445 |
| 127 | Primitive neuroectodermal tumor (HP:0030065) | 1.70883445 |
| 128 | Neuroblastic tumors (HP:0004376) | 1.70883445 |
| 129 | Peripheral primitive neuroectodermal neoplasm (HP:0030067) | 1.70883445 |
| 130 | Spastic paraparesis (HP:0002313) | 1.70038029 |
| 131 | Hand muscle atrophy (HP:0009130) | 1.69461373 |
| 132 | Distal arthrogryposis (HP:0005684) | 1.68918306 |
| 133 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.68637342 |
| 134 | Esotropia (HP:0000565) | 1.68535940 |
| 135 | Hyperthyroidism (HP:0000836) | 1.68317441 |
| 136 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.66987155 |
| 137 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.66802160 |
| 138 | Abnormality of renal resorption (HP:0011038) | 1.66691431 |
| 139 | Nephrogenic diabetes insipidus (HP:0009806) | 1.66183960 |
| 140 | Truncus arteriosus (HP:0001660) | 1.65500406 |
| 141 | Adrenal hypoplasia (HP:0000835) | 1.65497057 |
| 142 | Diminished motivation (HP:0000745) | 1.65370681 |
| 143 | Rimmed vacuoles (HP:0003805) | 1.65225851 |
| 144 | Focal seizures (HP:0007359) | 1.64534091 |
| 145 | Progressive cerebellar ataxia (HP:0002073) | 1.64232803 |
| 146 | Neoplasm of the adrenal gland (HP:0100631) | 1.63491801 |
| 147 | Nemaline bodies (HP:0003798) | 1.62577270 |
| 148 | Tetraparesis (HP:0002273) | 1.62390526 |
| 149 | Hypoventilation (HP:0002791) | 1.62204997 |
| 150 | Generalized tonic-clonic seizures (HP:0002069) | 1.61947704 |
| 151 | Failure to thrive in infancy (HP:0001531) | 1.61322185 |
| 152 | Axonal loss (HP:0003447) | 1.59863233 |
| 153 | Distal upper limb amyotrophy (HP:0007149) | 1.59063816 |
| 154 | Upper limb amyotrophy (HP:0009129) | 1.59063816 |
| 155 | Autoamputation (HP:0001218) | 1.57289125 |
| 156 | Apathy (HP:0000741) | 1.56195821 |
| 157 | Facial cleft (HP:0002006) | 1.56184813 |
| 158 | Abnormality of the motor neurons (HP:0002450) | 1.56043870 |
| 159 | Abnormal neuron morphology (HP:0012757) | 1.56043870 |
| 160 | Abnormality of the Achilles tendon (HP:0005109) | 1.53151189 |
| 161 | Hammertoe (HP:0001765) | 1.52925456 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ARAF | 3.46691025 |
| 2 | MAP3K12 | 3.10849297 |
| 3 | STK16 | 3.00115257 |
| 4 | BUB1 | 2.79531872 |
| 5 | NME1 | 2.74929118 |
| 6 | LIMK1 | 2.71468410 |
| 7 | RIPK4 | 2.55066718 |
| 8 | MAP3K9 | 2.44447779 |
| 9 | NTRK3 | 2.21443228 |
| 10 | MINK1 | 2.20154162 |
| 11 | PIM2 | 2.17193202 |
| 12 | NME2 | 2.17126877 |
| 13 | SRPK1 | 2.13121658 |
| 14 | CDC7 | 2.13119618 |
| 15 | ACVR1B | 2.07474989 |
| 16 | CAMKK2 | 2.01580477 |
| 17 | TTK | 1.98099394 |
| 18 | MAP3K11 | 1.93645524 |
| 19 | SCYL2 | 1.86956939 |
| 20 | RAF1 | 1.85728589 |
| 21 | KSR2 | 1.84670016 |
| 22 | LATS2 | 1.82206245 |
| 23 | PLK2 | 1.80162170 |
| 24 | MAPKAPK3 | 1.76767140 |
| 25 | TESK1 | 1.64488978 |
| 26 | MST1R | 1.61447276 |
| 27 | BMPR2 | 1.60933220 |
| 28 | BRAF | 1.60717262 |
| 29 | EIF2AK3 | 1.57345275 |
| 30 | EIF2AK1 | 1.55787342 |
| 31 | TRIM28 | 1.55548813 |
| 32 | VRK2 | 1.54070234 |
| 33 | MOS | 1.51364560 |
| 34 | PAK4 | 1.49538437 |
| 35 | NTRK1 | 1.47259919 |
| 36 | WEE1 | 1.45878537 |
| 37 | PDK2 | 1.44824508 |
| 38 | TESK2 | 1.41557882 |
| 39 | CSNK1G3 | 1.36036828 |
| 40 | KSR1 | 1.35377688 |
| 41 | GRK5 | 1.32968006 |
| 42 | BRSK1 | 1.32092973 |
| 43 | ERBB4 | 1.30257539 |
| 44 | VRK1 | 1.30050898 |
| 45 | RPS6KA4 | 1.29992848 |
| 46 | PLK1 | 1.25700348 |
| 47 | CCNB1 | 1.25495739 |
| 48 | MET | 1.24398919 |
| 49 | EPHA4 | 1.19401683 |
| 50 | CSNK1G2 | 1.18020032 |
| 51 | MAP2K7 | 1.16695177 |
| 52 | TSSK6 | 1.15425074 |
| 53 | BCKDK | 1.12028311 |
| 54 | DYRK2 | 1.10370054 |
| 55 | PNCK | 1.09111638 |
| 56 | CSNK1A1L | 1.08522885 |
| 57 | PTK2 | 1.01861708 |
| 58 | DAPK1 | 1.01167002 |
| 59 | CASK | 0.98383021 |
| 60 | MAP2K1 | 0.96612266 |
| 61 | CDK11A | 0.96367730 |
| 62 | ERBB3 | 0.94976690 |
| 63 | CSNK1G1 | 0.94230146 |
| 64 | MARK1 | 0.93970993 |
| 65 | PINK1 | 0.93137125 |
| 66 | MAP3K13 | 0.89483035 |
| 67 | ABL2 | 0.89452599 |
| 68 | AURKA | 0.88721097 |
| 69 | MAP3K5 | 0.88171539 |
| 70 | DYRK3 | 0.88054889 |
| 71 | MAP3K2 | 0.88017166 |
| 72 | AURKB | 0.85575882 |
| 73 | EPHB2 | 0.85302459 |
| 74 | CDK19 | 0.84850320 |
| 75 | BCR | 0.84838259 |
| 76 | PBK | 0.83469846 |
| 77 | MAPK15 | 0.83069215 |
| 78 | CHEK2 | 0.80978787 |
| 79 | MAP3K3 | 0.79666434 |
| 80 | CDK14 | 0.79336238 |
| 81 | PIK3CG | 0.79021335 |
| 82 | PAK1 | 0.76401138 |
| 83 | GRK7 | 0.75831809 |
| 84 | IRAK3 | 0.75461471 |
| 85 | PRKCG | 0.73444860 |
| 86 | PLK4 | 0.71757292 |
| 87 | IRAK1 | 0.71654031 |
| 88 | ADRBK1 | 0.67894829 |
| 89 | BMX | 0.65485475 |
| 90 | NEK1 | 0.65203401 |
| 91 | BMPR1B | 0.65095661 |
| 92 | MUSK | 0.64480050 |
| 93 | PAK6 | 0.62972743 |
| 94 | BRSK2 | 0.62457089 |
| 95 | MAPKAPK5 | 0.62002782 |
| 96 | CAMK2A | 0.60210358 |
| 97 | DMPK | 0.59996195 |
| 98 | EPHA2 | 0.59788169 |
| 99 | FER | 0.59006353 |
| 100 | DAPK3 | 0.57500094 |
| 101 | MAP3K8 | 0.57337674 |
| 102 | TNIK | 0.57137030 |
| 103 | LMTK2 | 0.55808456 |
| 104 | UHMK1 | 0.54701593 |
| 105 | MAP3K1 | 0.54695088 |
| 106 | PLK3 | 0.54269992 |
| 107 | PRKCE | 0.53061387 |
| 108 | CDK5 | 0.52582576 |
| 109 | MYLK | 0.52528569 |
| 110 | NEK2 | 0.51645041 |
| 111 | MAP2K4 | 0.50577203 |
| 112 | TLK1 | 0.50194313 |
| 113 | SIK3 | 0.50050923 |
| 114 | DYRK1A | 0.49155126 |
| 115 | FRK | 0.48963697 |
| 116 | PAK3 | 0.48349320 |
| 117 | CAMK2B | 0.48211121 |
| 118 | MAP3K6 | 0.48197055 |
| 119 | KDR | 0.47817905 |
| 120 | YES1 | 0.47729463 |
| 121 | STK38L | 0.46815915 |
| 122 | PTK2B | 0.46257639 |
| 123 | CDK7 | 0.45819481 |
| 124 | AKT2 | 0.44940300 |
| 125 | MAP3K4 | 0.44853667 |
| 126 | CAMK2D | 0.44507761 |
| 127 | ADRBK2 | 0.44309636 |
| 128 | MKNK1 | 0.44179195 |
| 129 | CDK18 | 0.43455305 |
| 130 | PRKD3 | 0.42941932 |
| 131 | CSNK2A1 | 0.42489572 |
| 132 | CAMK2G | 0.42152835 |
| 133 | PHKG2 | 0.41405254 |
| 134 | PHKG1 | 0.41405254 |
| 135 | CDK8 | 0.41363807 |
| 136 | MST4 | 0.41344974 |
| 137 | MAPK13 | 0.40896646 |
| 138 | CHEK1 | 0.38604595 |
| 139 | ATR | 0.38524759 |
| 140 | TAOK2 | 0.36500415 |
| 141 | CSNK2A2 | 0.35849384 |
| 142 | CDK15 | 0.35565826 |
| 143 | ILK | 0.35507516 |
| 144 | DDR2 | 0.35495263 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.18397984 |
| 2 | Parkinsons disease_Homo sapiens_hsa05012 | 3.61955798 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 3.60901469 |
| 4 | Protein export_Homo sapiens_hsa03060 | 2.92400400 |
| 5 | Alzheimers disease_Homo sapiens_hsa05010 | 2.84988089 |
| 6 | Huntingtons disease_Homo sapiens_hsa05016 | 2.77137438 |
| 7 | Ribosome_Homo sapiens_hsa03010 | 2.52565414 |
| 8 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.15975802 |
| 9 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.13612710 |
| 10 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.09588598 |
| 11 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.96141092 |
| 12 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.95753875 |
| 13 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.95221524 |
| 14 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.90477953 |
| 15 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.89759319 |
| 16 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.88766716 |
| 17 | RNA polymerase_Homo sapiens_hsa03020 | 1.78009117 |
| 18 | Carbon metabolism_Homo sapiens_hsa01200 | 1.70553974 |
| 19 | Nicotine addiction_Homo sapiens_hsa05033 | 1.62704037 |
| 20 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.62570881 |
| 21 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.59308604 |
| 22 | Long-term potentiation_Homo sapiens_hsa04720 | 1.59186666 |
| 23 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.57659400 |
| 24 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.52345715 |
| 25 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.50289950 |
| 26 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.48754518 |
| 27 | Sulfur relay system_Homo sapiens_hsa04122 | 1.45092647 |
| 28 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.44364349 |
| 29 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.44302808 |
| 30 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.41438661 |
| 31 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.39737084 |
| 32 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.37736292 |
| 33 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.28950020 |
| 34 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.28622364 |
| 35 | Taste transduction_Homo sapiens_hsa04742 | 1.28303363 |
| 36 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.27698225 |
| 37 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.25754403 |
| 38 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.22518751 |
| 39 | Circadian entrainment_Homo sapiens_hsa04713 | 1.19547076 |
| 40 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.18520362 |
| 41 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.17567637 |
| 42 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.16745741 |
| 43 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.14743683 |
| 44 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.14702466 |
| 45 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.12188559 |
| 46 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.12134581 |
| 47 | Insulin secretion_Homo sapiens_hsa04911 | 1.10074219 |
| 48 | Long-term depression_Homo sapiens_hsa04730 | 1.08328568 |
| 49 | Galactose metabolism_Homo sapiens_hsa00052 | 1.07080601 |
| 50 | GABAergic synapse_Homo sapiens_hsa04727 | 1.02556326 |
| 51 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.02260466 |
| 52 | DNA replication_Homo sapiens_hsa03030 | 1.01811222 |
| 53 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.01160337 |
| 54 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.00524901 |
| 55 | Shigellosis_Homo sapiens_hsa05131 | 0.94550133 |
| 56 | Circadian rhythm_Homo sapiens_hsa04710 | 0.91818193 |
| 57 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.91619126 |
| 58 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.86776365 |
| 59 | Gap junction_Homo sapiens_hsa04540 | 0.86744243 |
| 60 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.85884532 |
| 61 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.85700997 |
| 62 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.85298996 |
| 63 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.83687858 |
| 64 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.83364319 |
| 65 | Morphine addiction_Homo sapiens_hsa05032 | 0.81890435 |
| 66 | Phagosome_Homo sapiens_hsa04145 | 0.80968731 |
| 67 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.80658807 |
| 68 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.80379671 |
| 69 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.79560342 |
| 70 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.79449612 |
| 71 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.79262837 |
| 72 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.78945822 |
| 73 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.74697578 |
| 74 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.74681338 |
| 75 | RNA transport_Homo sapiens_hsa03013 | 0.72914785 |
| 76 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.72505734 |
| 77 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.72360830 |
| 78 | Thyroid cancer_Homo sapiens_hsa05216 | 0.72024576 |
| 79 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.71817622 |
| 80 | Olfactory transduction_Homo sapiens_hsa04740 | 0.71729542 |
| 81 | Spliceosome_Homo sapiens_hsa03040 | 0.70711450 |
| 82 | Melanogenesis_Homo sapiens_hsa04916 | 0.69534346 |
| 83 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.68745399 |
| 84 | Cocaine addiction_Homo sapiens_hsa05030 | 0.67592054 |
| 85 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.67523264 |
| 86 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.66667570 |
| 87 | Renin secretion_Homo sapiens_hsa04924 | 0.66020113 |
| 88 | Purine metabolism_Homo sapiens_hsa00230 | 0.65862847 |
| 89 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.65038358 |
| 90 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.64960674 |
| 91 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.64789288 |
| 92 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.64591054 |
| 93 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.64193324 |
| 94 | Lysosome_Homo sapiens_hsa04142 | 0.63034643 |
| 95 | Metabolic pathways_Homo sapiens_hsa01100 | 0.60889982 |
| 96 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.60152171 |
| 97 | Mismatch repair_Homo sapiens_hsa03430 | 0.59732646 |
| 98 | Salivary secretion_Homo sapiens_hsa04970 | 0.59224245 |
| 99 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.55416117 |
| 100 | RNA degradation_Homo sapiens_hsa03018 | 0.54974134 |
| 101 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.53995164 |
| 102 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.53732191 |
| 103 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51718547 |
| 104 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.51035342 |
| 105 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.51004006 |
| 106 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.50966635 |
| 107 | Cell cycle_Homo sapiens_hsa04110 | 0.50881693 |
| 108 | Legionellosis_Homo sapiens_hsa05134 | 0.50182498 |
| 109 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.50051729 |
| 110 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.49547530 |
| 111 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.49165625 |
| 112 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.48243682 |
| 113 | Alcoholism_Homo sapiens_hsa05034 | 0.47936878 |
| 114 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.46766683 |
| 115 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.45845142 |
| 116 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.44820212 |
| 117 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.43292864 |
| 118 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.42183369 |
| 119 | Salmonella infection_Homo sapiens_hsa05132 | 0.42006178 |
| 120 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.41881612 |
| 121 | Other glycan degradation_Homo sapiens_hsa00511 | 0.41687530 |
| 122 | Basal transcription factors_Homo sapiens_hsa03022 | 0.40819307 |
| 123 | Bladder cancer_Homo sapiens_hsa05219 | 0.40761510 |
| 124 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.40620543 |
| 125 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.40091995 |
| 126 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.38993903 |
| 127 | Melanoma_Homo sapiens_hsa05218 | 0.38073510 |
| 128 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.37724567 |
| 129 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.37257320 |
| 130 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.36558738 |
| 131 | Glioma_Homo sapiens_hsa05214 | 0.36442525 |
| 132 | Prion diseases_Homo sapiens_hsa05020 | 0.36225970 |
| 133 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.35423448 |
| 134 | Pertussis_Homo sapiens_hsa05133 | 0.32935053 |
| 135 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.28941996 |
| 136 | Tuberculosis_Homo sapiens_hsa05152 | 0.28702342 |
| 137 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.28249159 |
| 138 | Base excision repair_Homo sapiens_hsa03410 | 0.28190415 |
| 139 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.27439535 |
| 140 | Homologous recombination_Homo sapiens_hsa03440 | 0.26805149 |
| 141 | Colorectal cancer_Homo sapiens_hsa05210 | 0.26706972 |
| 142 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.26595486 |
| 143 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.23145181 |
| 144 | Adherens junction_Homo sapiens_hsa04520 | 0.20107747 |
| 145 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.19249689 |
| 146 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.17688792 |
| 147 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.15894567 |
| 148 | Peroxisome_Homo sapiens_hsa04146 | 0.14365204 |

